Yan Xie Selected Research

Critical Care (Surgical Intensive Care)

12/2023	Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study.
11/2023	Interpretable machine-learning model for real-time, clustered risk factor analysis of sepsis and septic death in critical care.
1/2023	Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
1/2023	Long-term gastrointestinal outcomes of COVID-19.
1/2022	Risks and burdens of incident diabetes in long COVID: a cohort study.
1/2022	Long-term cardiovascular outcomes of COVID-19.
11/2021	Kidney Outcomes in Long COVID.
1/2021	High-dimensional characterization of post-acute sequelae of COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Xie Research Topics

Disease

82	Neoplasms (Cancer) 05/2024 - 09/2007
32	Infections 12/2023 - 08/2011
18	Breast Neoplasms (Breast Cancer) 01/2024 - 07/2009
18	COVID-19 12/2023 - 06/2020
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2003
13	Inflammation (Inflammations) 10/2023 - 02/2011
13	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2009
11	Obesity 11/2023 - 11/2006
11	Chronic Renal Insufficiency 12/2020 - 01/2014
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 04/2016
10	Fibrosis (Cirrhosis) 01/2024 - 07/2002
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 10/2011
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 12/2012
9	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 10/2011
9	Lymphoma (Lymphomas) 08/2023 - 10/2011
8	Extranodal NK-T-Cell Lymphoma 01/2024 - 07/2009
8	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 03/2006
8	Necrosis 01/2024 - 07/2008
8	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 09/2007
8	Kidney Diseases (Kidney Disease) 01/2023 - 01/2014
8	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2016
8	Hypoxia (Hypoxemia) 01/2020 - 12/2004
7	Carcinogenesis 01/2024 - 01/2010
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2007
7	Tuberculosis (Tuberculoses) 01/2022 - 11/2015
7	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 07/2007
6	Body Weight (Weight, Body) 12/2023 - 07/2002
6	Liver Diseases (Liver Disease) 01/2023 - 07/2009
6	Cicatrix (Scar) 08/2022 - 11/2010
6	Asthma (Bronchial Asthma) 01/2022 - 09/2010
6	Wounds and Injuries (Trauma) 01/2022 - 06/2008
6	Weight Gain 01/2021 - 11/2004
6	Hypersensitivity (Allergy) 01/2021 - 09/2000
5	Hemorrhage 04/2024 - 01/2014
5	Pain (Aches) 03/2024 - 10/2009
5	Non-alcoholic Fatty Liver Disease 01/2023 - 07/2013
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2010
5	Hypertrophic Cicatrix (Hypertrophic Scar) 08/2022 - 11/2010
5	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2014
5	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2014
5	Respiratory Hypersensitivity 11/2020 - 08/2012
5	Gallstones (Gallstone) 01/2017 - 05/2009
4	Fatigue 02/2024 - 10/2009
4	Virus Diseases (Viral Diseases) 02/2024 - 02/2014
4	Glioma (Gliomas) 12/2023 - 03/2015

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2007
18	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2016
15	Messenger RNA (mRNA)IBA 08/2023 - 09/2007
13	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 11/2008
13	LipidsIBA 01/2023 - 11/2004
11	CholesterolIBA 01/2023 - 02/2006
11	Long Noncoding RNAIBA 01/2022 - 11/2019
10	CytokinesIBA 01/2023 - 02/2011
9	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2007
9	CreatinineIBA 11/2021 - 01/2014
8	CollagenIBA 01/2024 - 02/2015
8	Asparaginase (Elspar)FDA Link 09/2022 - 03/2006
8	O(4)-methylthymidine triphosphateIBA 01/2021 - 02/2006
7	Oxygen (Dioxygen)IBA 03/2024 - 02/2010
7	Therapeutic UsesIBA 01/2024 - 01/2007
7	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2016
7	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2014
7	Particulate MatterIBA 01/2021 - 10/2017
7	Rituximab (Mabthera)FDA Link 01/2019 - 01/2007
6	Small Interfering RNA (siRNA)IBA 01/2024 - 07/2009
6	VaccinesIBA 12/2023 - 01/2018
6	AcidsIBA 01/2023 - 01/2008
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2015 - 07/2009
5	Hyaluronic Acid (Hyaluronan)IBA 05/2024 - 01/2017
5	CateninsIBA 01/2024 - 10/2013
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 12/2013
5	AlbuminsIBA 01/2023 - 01/2014
5	VenomsIBA 01/2023 - 11/2011
5	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
5	Viral DNAIBA 01/2022 - 08/2011
5	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 06/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2009
5	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 07/2013
5	FructoseIBA 01/2021 - 01/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 07/2013
5	ChylomicronsIBA 01/2021 - 01/2012
5	Proton Pump InhibitorsIBA 01/2020 - 08/2011
5	microsomal triglyceride transfer proteinIBA 10/2019 - 01/2012
5	EnzymesIBA 12/2017 - 10/2011
4	Dextrans (Dextran)FDA Link 05/2024 - 01/2013
4	MicellesIBA 05/2024 - 01/2017
4	HDL CholesterolIBA 03/2024 - 04/2016
4	C-Reactive ProteinIBA 03/2024 - 03/2014
4	Antiviral Agents (Antivirals)IBA 02/2024 - 01/2023
4	Polysaccharides (Glycans)IBA 01/2024 - 05/2017
4	Uric Acid (Urate)IBA 01/2024 - 06/2020
4	N-(2-cyanoethylene)urea (BA 1)IBA 12/2023 - 01/2022

Therapy/Procedure

53	Therapeutics 03/2024 - 06/2008
20	Drug Therapy (Chemotherapy) 05/2024 - 03/2006
8	Transplantation 04/2024 - 02/2013
8	Critical Care (Surgical Intensive Care) 12/2023 - 01/2021
7	Liver Transplantation 01/2023 - 02/2011
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 03/2015
5	Radiotherapy 01/2022 - 07/2013